Xeris Biopharma Holdings, Inc. Quarterly Operating Lease, Liability, Current in USD from Q4 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
Summary
Xeris Biopharma Holdings, Inc. quarterly Operating Lease, Liability, Current history and growth rate from Q4 2021 to Q2 2024.
  • Xeris Biopharma Holdings, Inc. Operating Lease, Liability, Current for the quarter ending June 30, 2024 was $5.31M, a 174% increase year-over-year.
Operating Lease, Liability, Current, Quarterly (USD)
Operating Lease, Liability, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $5.31M +$3.37M +174% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $4.62M +$3.18M +219% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $3.5M +$1.92M +121% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 $2.37M Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $1.94M Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $1.45M Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $1.58M +$1.58M Dec 31, 2022 10-K 2024-03-06
Q4 2021 $0 Dec 31, 2021 10-K 2023-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.